Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience

Real-world predictors of the treatment efficacy of immune checkpoint inhibitors for hepatocellular carcinoma (HCC) are unknown. This retrospective study enrolled 87 consecutive patients with unresectable HCC from May 2017 to December 2019 at two hospitals. Of the 87 patients, 7, 9, 60, and 11 patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Cancer Res
Main Authors: Hsu, Wei-Fan, Chuang, Po-Heng, Chen, Cheng-Kuo, Wang, Hung-Wei, Tsai, Ming-Hung, Su, Wen-Pang, Chen, Hung-Yao, Yang, Chi-Ying, Lin, Chun-Che, Huang, Guan-Tarn, Lin, Jaw-Town, Lai, Hsueh-Chou, Peng, Cheng-Yuan
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783753/
https://ncbi.nlm.nih.gov/pubmed/33415018
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki